OTC Markets OTCQB - Delayed Quote USD

BioHarvest Sciences Inc. (CNVCF)

Compare
5.28 -0.02 (-0.38%)
At close: 1:21 PM EDT
Loading Chart for CNVCF
DELL
  • Previous Close 5.30
  • Open 5.28
  • Bid 5.13 x 40000
  • Ask 5.29 x 40000
  • Day's Range 5.28 - 5.28
  • 52 Week Range 0.00 - 7.38
  • Volume 310
  • Avg. Volume 1,828
  • Market Cap (intraday) 91.49M
  • Beta (5Y Monthly) 1.48
  • PE Ratio (TTM) --
  • EPS (TTM) -1.26
  • Earnings Date Nov 26, 2024 - Dec 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

www.bioharvest.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CNVCF

View More

Performance Overview: CNVCF

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CNVCF
3,241.77%
S&P/TSX Composite index
17.19%

1-Year Return

CNVCF
3,961.54%
S&P/TSX Composite index
26.19%

3-Year Return

CNVCF
1,820.00%
S&P/TSX Composite index
17.36%

5-Year Return

CNVCF
2,278.38%
S&P/TSX Composite index
36.13%

Compare To: CNVCF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNVCF

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    91.51M

  • Enterprise Value

    96.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.50

  • Price/Book (mrq)

    15.49

  • Enterprise Value/Revenue

    5.06

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -84.84%

  • Return on Assets (ttm)

    -25.83%

  • Return on Equity (ttm)

    -5,955.96%

  • Revenue (ttm)

    19.13M

  • Net Income Avi to Common (ttm)

    -16.23M

  • Diluted EPS (ttm)

    -1.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.17M

  • Total Debt/Equity (mrq)

    155.00%

  • Levered Free Cash Flow (ttm)

    -5.96M

Company Insights: CNVCF

People Also Watch